Early Recurrent Ischemic Stroke Complicating Intravenous Thrombolysis for Stroke
Author(s) -
Mostafa Awadh,
Niall MacDougall,
Celestine Santosh,
Evelyn Teasdale,
Tracey Baird,
Keith W. Muir
Publication year - 2010
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.109.569459
Subject(s) - medicine , thrombolysis , stroke (engine) , atrial fibrillation , intracerebral hemorrhage , cardiology , middle cerebral artery , cerebral infarction , infarction , surgery , anesthesia , ischemia , myocardial infarction , subarachnoid hemorrhage , mechanical engineering , engineering
Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early recurrent ischemic stroke. We observed a number of cases of acute deterioration due to recurrent ischemic events.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom